HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Garnero Selected Research

Collagen Type II (Type II Collagen)

2/2011Urinary type II collagen C-terminal peptide is associated with synovitis and predicts structural bone loss in very early inflammatory arthritis.
10/2008PIIANP and HELIXII diurnal variation.
10/2008The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation.
6/2008Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.
5/2008Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage.
6/2007A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.
12/2006Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis.
3/2006Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study.
1/2006Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis.
9/2005Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Garnero Research Topics

Disease

29Bone Resorption
02/2011 - 02/2000
12Osteoporosis
02/2011 - 01/2000
11Osteoarthritis
08/2012 - 05/2001
10Rheumatoid Arthritis
02/2011 - 07/2000
9Knee Osteoarthritis
10/2015 - 06/2001
6Arthritis (Polyarthritis)
02/2011 - 05/2001
6Inflammation (Inflammations)
10/2009 - 06/2001
6Neoplasm Metastasis (Metastasis)
07/2007 - 02/2000
5Body Weight (Weight, Body)
04/2008 - 01/2001
5Joint Diseases (Joint Disease)
01/2006 - 05/2000
4Pain (Aches)
12/2009 - 06/2001
4Postmenopausal Osteoporosis
09/2007 - 01/2000
3Disease Progression
10/2008 - 05/2007
3Necrosis
03/2008 - 08/2002
3Osteoporotic Fractures
04/2001 - 03/2000
2Metabolic Bone Diseases (Osteopenia)
04/2012 - 09/2007
2Synovitis
02/2011 - 09/2003
2Ankylosing Spondylitis
08/2008 - 10/2001
2Osteophyte
12/2007 - 07/2006
2Breast Neoplasms (Breast Cancer)
07/2007 - 08/2006
2Hip Osteoarthritis (Coxarthrosis)
12/2006 - 10/2003
2Secondary Hyperparathyroidism
03/2002 - 02/2002
2Hip Fractures (Intertrochanteric Fractures)
03/2002 - 08/2000
2Prostatic Neoplasms (Prostate Cancer)
06/2001 - 02/2000
2Osteitis Deformans (Paget's Disease of Bone)
05/2001 - 03/2001
1Stress Fractures (Stress Fracture)
09/2009
1Multiple Myeloma
03/2009
1type 2 alpha 1 Collagenopathy
10/2008
1Sclerosis
12/2007
1Fever (Fevers)
07/2007
1Neoplasms (Cancer)
05/2007
1Carcinogenesis
05/2007
1Vitamin D Deficiency
03/2007
1Osteogenesis Imperfecta (Lobstein Disease)
01/2006
1Spondylarthropathies
08/2005
1Congenital Abnormalities (Deformity)
06/2003
1Bone Diseases (Bone Disease)
01/2003

Drug/Important Bio-Agent (IBA)

34Biomarkers (Surrogate Marker)IBA
08/2012 - 01/2000
23Collagen Type I (Type I Collagen)IBA
03/2009 - 02/2000
15Collagen Type II (Type II Collagen)IBA
02/2011 - 05/2001
12collagen type I trimeric cross-linked peptideIBA
02/2011 - 02/2000
10OsteocalcinIBA
03/2009 - 02/2000
9CollagenIBA
09/2009 - 08/2002
6deoxypyridinolineIBA
01/2005 - 02/2000
5Proteins (Proteins, Gene)FDA Link
10/2009 - 08/2002
4Peptides (Polypeptides)IBA
02/2011 - 06/2001
4Alkaline PhosphataseIBA
09/2007 - 07/2002
4pyridinolineIBA
07/2006 - 06/2001
4alpha- D- glucopyranosyl- (1- 2)- beta- D- galactopyranosyl- O- pyridinolineIBA
07/2006 - 03/2001
4Estradiol (Delestrogen)FDA LinkGeneric
06/2005 - 01/2000
4Interleukin-6 (Interleukin 6)IBA
01/2003 - 01/2001
4Diphosphonates (Bisphosphonates)IBA
01/2003 - 02/2000
3Pharmaceutical PreparationsIBA
05/2011 - 09/2005
3Collagen Type III (Type III Collagen)IBA
10/2009 - 06/2001
3ProcollagenIBA
10/2008 - 06/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2008 - 08/2002
3Zoledronic Acid (Zometa)FDA Link
09/2007 - 05/2001
3Vitamin DFDA LinkGeneric
03/2007 - 03/2002
2PeriostinIBA
10/2015 - 04/2012
2OsteoprotegerinIBA
03/2009 - 06/2006
2Tartrate-Resistant Acid PhosphataseIBA
03/2009 - 08/2006
2Risedronic Acid (Actonel)FDA LinkGeneric
06/2008 - 06/2003
2tiludronic acid (tiludronate)FDA Link
04/2008 - 09/2007
2Matrix Metalloproteinases (MMPs)IBA
03/2008 - 05/2003
2CytokinesIBA
03/2008 - 01/2003
2Biological ProductsIBA
12/2007 - 08/2006
2Insulin-Like Growth Factor I (IGF-1)IBA
08/2005 - 03/2000
2CalciumIBA
06/2003 - 03/2002
2C-Reactive ProteinIBA
01/2003 - 06/2001
1Procollagen Type IIBA
02/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2009
1Tyrosine (L-Tyrosine)FDA Link
10/2009
1Simvastatin (Zocor)FDA LinkGeneric
03/2009
1CholesterolIBA
03/2009
1Blood Proteins (Serum Proteins)IBA
01/2009
1Peptide Hydrolases (Proteases)FDA Link
10/2008
1Cathepsin KIBA
03/2008
1Metalloproteases (Metalloproteinases)IBA
03/2008
1Infliximab (Remicade)FDA Link
03/2008
1IsoenzymesIBA
09/2007
1Ibandronic Acid (Boniva)FDA Link
07/2007
1Tumor Biomarkers (Tumor Markers)IBA
05/2007
1Trastuzumab (Herceptin)FDA Link
05/2007
1Tissue Inhibitor of Metalloproteinase-1IBA
08/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2006
1Parathyroid Hormone (Parathormone)IBA
04/2006
1Rheumatoid FactorIBA
01/2006
1nomegestrol acetateIBA
06/2005
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2004
1Ibuprofen (Motrin)FDA LinkGeneric
07/2004
1Matrix Metalloproteinase InhibitorsIBA
05/2003
1alpha 1 Chain Collagen Type IIBA
01/2003
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
08/2002
1Interleukin-1 (Interleukin 1)IBA
08/2002
1Cholecalciferol (Vitamin D3)FDA Link
03/2002
125-hydroxyvitamin DIBA
02/2002

Therapy/Procedure

5Therapeutics
05/2011 - 04/2001
1Intravenous Administration
04/2008
1Contraindications
06/2005
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
06/2005